If you are already looking for a way to make next year’s Thanksgiving meal more festive and relaxed you may want to consider a new product that’s available in limited markets in California—cannabis-infused turkey gravy.
A company called Kiva has created a single-serve gravy infused with 10mg of THC. It uses traditional Thanksgiving ingredients such as turkey stock, salt, onion and garlic to create what it calls a familiar taste with an uncommon ingredient—cannabis.
Instructions on the company’s website says to “simply whisk the gravy powder with one cup of water in a saucepan, bring to a boil, and stir occasionally to achieve your desired level of thickness.” We assume they are describing the gravy and not your state of mind.
The company claims it uses “cutting-edge technology” when making the gravy that allows it to take effect in what would seem to be a remarkable 2 to 15 minutes, which—if accurate—would make it one of the fastest-acting and most bioavailable cannabinoids present in edibles today.
According to Kiva’s Co-Founder and CEO Scott Palmer, “Fast-acting edibles technology is an exciting industry innovation because it has the potential to change the way people use edibles, breaking down the barriers to entry,”
The company also produces other edibles such as chocolate bars blended with flavors such as toffee or mint and a line of gummies with flavors such as pineapple-habanero, sparkling prosecco pear, and blenheim apricot.
To learn more, visit the company’s website below.
kivaconfections.com/products/bars
Second Thoughts on Gateway Drugs
Demonstrating what some might categorize as a lateral conceptual arabesque, Presidential candidate Joe Biden walked away from the position that cannabis is a gateway drug, the use of which leads to the use of other drugs, such as opioids.
According to Kyle Jaeger, reporting for Marijuana Moment, in a call with reporters the former Vice President denied that he made the claim in the first place. “I didn’t,” he said. “I said some say pot was a gateway drug.”
Jaeger reported that Biden made it clear that he supports decriminalization, expunging prior records, releasing those incarcerated for marijuana offenses and the “rescheduling” of cannabis.
During the same call the former Vice President formally walked back his position on whether existing scientific research demonstrates that cannabis leads to the use of other substances.
“I don’t think it is a gateway drug. There’s no evidence I’ve seen to suggest that.”
Biden, however, does not yet favor legalization at the national level. During the same phone conversation with reporters, he said, “It’s a debate, and I want a lot more before I legalize it nationally.”
We presume he was talking about information.
To learn more, you can read Kyle Jaeger’s detailed reporting in the November 25, 2019 edition of Marijuana Moment.
www.marijuanamoment.net/joe-biden-walks-back-marijuana-gateway-drug-comment-after-week-of-criticism/
CBD and the Anxiety Economy
A growing number of beverage companies seem to be responding to Taylor Swift’s advice to “calm down” by producing products that are supposed to have a calming effect on those who use them. In many cases manufacturers are turning to CBD, as well as other wellness-oriented ingredients, such as turmeric, to create what some in the beverage industry call “functional beverages.”
So says Alicia Kennedy writing for the website EATER. Kennedy notes that it’s possible to enter stores and find entire display cases filled with beverages designed to take advantage of what she and others refer to as the “anxiety economy” by taking the edge off of daily life.
She points to a beverage called “Recess” as one example in particular. Benjamin Witte, the company’s founder, uses a daily dose of CBD tincture to deal with his stress, a treatment that he says makes him feel more balanced and even-keeled.
Said Witte, “While CBD was effective for me, the user experience [of] putting oil under your tongue a few times a day is not a great one.” So to him the idea of adding hemp extract to a beverage seemed like a way to combine—and market—wellness with convenience.
According to Kennedy, CBD is what’s known as a functional ingredient — a bioactive compound that can, like caffeine, be added to many things. She points out that Recess’s packaging doesn’t mention CBD. Rather, each can of Recess is said to contain 10 milligrams of broad-spectrum hemp oil.
Alicia Kennedy’s insightful writing does a good job of unpacking a number issues surrounding the public’s desire for wellness, the anxiety economy and the way CBD is being used as the “flavor of the month” in a wide variety of products. You can learn more by reading her article in the November 25, 2019 issue of EATER.
www.eater.com/2019/11/25/20974579/wellness-drinks-cbd-recess-turmeric-cha-cha-matcha
Senior Cannabis Digest is compiled and edited by Joe Kohut and John Kohut. You can contact them at joe.kohut@gmail.com or 347-528-8753.
